TNF and neoplasm: Tarrus et al. showed that a pretargeting approach with biotinylated recombinant TNF-related apoptosis-inducing ligands (TRAILs) targeting RGD-avidin, bound on angiogenic endothelial cells via the αvβ3 integrin receptor, enhanced tumor cell death even further through increased tumor accumulation of these ligands [136].